对神经母细胞瘤进行抗GD2抗体治疗的二次双边增强型瞳孔
Christopher M Edwards1, Daniel Elefant2, Michael S Isakoff3
1University of Connecticut School of Medicine, Farmington, Connecticut.
概括
一名患有4期神经母细胞瘤的12岁女孩在接受dinutuximab免疫治疗后经历了强烈的瞳孔. 这种不良影响的特点是瞳孔膨胀和阅读困难,经过皮洛卡尔测试证实了这一现象.
科学领域:
- 儿科瘤学 儿科瘤学
- 神经眼科神经眼科
- 免疫治疗不良影响 免疫治疗不良影响
背景情况:
- 神经母细胞瘤是一种小儿癌症,可以使用像dinutuximab这样的免疫疗法来治疗.
- 丁西马布向GD2抗原,这种抗原通常在神经母细胞瘤细胞上发现.
- 了解免疫疗法副作用对于患者管理至关重要.
更多相关视频
13:12Partial Optic Nerve Transection in Rats: A Model Established with a New Operative Approach to Assess Secondary Degeneration of Retinal Ganglion Cells
Published on: October 15, 2017
11.3K
06:35Experimental Glaucoma Induced by Ocular Injection of Magnetic Microspheres
Published on: February 2, 2015
17.2K
相关概念视频
01:20Myasthenia Gravis: Overview and Treatment
1.4K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
1.4K
01:15Myasthenia Gravis: Diagnostic Tests
840
Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
840